Cambridge NeuroTech develops high-channel-count silicon neural probes and miniature headstages designed for advanced electrophysiology research. The company’s hardware enables precise recording and stimulation of neural activity across large numbers of channels. Its products are engineered to support demanding experimental setups where signal quality and stability are critical. Cambridge NeuroTech operates primarily within neuroscience research and preclinical development environments.

The technology is based on silicon probe architectures that support dense electrode arrays with fine spatial resolution. These probes are paired with ultra-small headstages that minimize noise and movement-related artifacts during recording. The systems are compatible with optogenetic techniques, allowing simultaneous optical stimulation and electrical recording. This integration supports complex experiments requiring coordinated neural manipulation and measurement.

Cambridge NeuroTech targets academic and industrial neuroscience researchers studying neural circuits, brain function, and disease models. The platforms are intended for laboratory and preclinical use rather than clinical deployment. Its focus on high channel counts and artifact reduction reflects ongoing demand for scalable, high-fidelity tools in systems neuroscience and neurotechnology research.